Primary microcephaly (MCPH) is characterized by reduced brain size and intellectual disability 1 . The exact pathophysiological mechanism underlying MCPH remains to be elucidated, but dysfunction of neuronal progenitors in the developing neocortex plays a major role 1 . Using homozygosity mapping and whole exome sequencing, we identified a homozygous missense mutation (p.W155C) in Ribosomal RNA Processing 7 Homolog A, RRP7A, which segregated with MCPH in a consanguineous family with 10 affected individuals. RRP7A is expressed in neural stem cells/radial glial cells of the developing human forebrain, and targeted mutation of Rrp7a leads to defects in both neurogenesis and proliferation in a mouse stem cell model. RRP7A localizes to centrosomes, cilia and nucleoli, and patient-derived fibroblasts display defects in processing of ribosomal RNA, resorption of primary cilia and cell cycle progression. Finally, analysis of zebrafish embryos with loss-offunction mutation in rrp7a confirmed that RRP7A depletion causes reduced brain size, impaired neurogenesis and cell proliferation as well as defective ribosomal RNA processing. These findings provide novel insight into human brain development and MCPH.
Introductory paragraph
Primary microcephaly (MCPH) is characterized by reduced brain size and intellectual disability 1 . The exact pathophysiological mechanism underlying MCPH remains to be elucidated, but dysfunction of neuronal progenitors in the developing neocortex plays a major role 1 . Using homozygosity mapping and whole exome sequencing, we identified a homozygous missense mutation (p.W155C) in Ribosomal RNA Processing 7 Homolog A, RRP7A, which segregated with MCPH in a consanguineous family with 10 affected individuals. RRP7A is expressed in neural stem cells/radial glial cells of the developing human forebrain, and targeted mutation of Rrp7a leads to defects in both neurogenesis and proliferation in a mouse stem cell model. RRP7A localizes to centrosomes, cilia and nucleoli, and patient-derived fibroblasts display defects in processing of ribosomal RNA, resorption of primary cilia and cell cycle progression. Finally, analysis of zebrafish embryos with loss-offunction mutation in rrp7a confirmed that RRP7A depletion causes reduced brain size, impaired neurogenesis and cell proliferation as well as defective ribosomal RNA processing. These findings provide novel insight into human brain development and MCPH.
Main
During development of the human neocortex, neuroepithelial cells (NECs) multiply by symmetric cell division to create an initial pool of neural progenitors (NPCs), which differentiate into apical radial glial cells (RGCs) in the ventricular (VZ) and inner subventricular (ISVZ) zones as well as to basal RGCs at the outer subventricular zone (OSVZ) 2 . RGCs undergo a complex pattern of symmetric and asymmetric cell divisions and differentiation, which expands the NPC pool and produces post-mitotic neurons 3, 4 . Tight regulation of cell division and differentiation in NECs, RGCs and their progeny is important for proper NPC expansion and ultimately the number of cortical neurons 5 . This number is reduced in autosomal recessive primary microcephaly (MCPH; MIM #251200); a rare neurodevelopmental disorder characterized by congenital reduction in occipitofrontal circumference due to hypoplasia of the cerebral cortex causing reduction in brain volume and a simplified gyral pattern. MCPH patients display varying degree of non-progressive cognitive dysfunction.
Additionally, most MCPH patients typically show sloping forehead, but no other facial or physical abnormalities 6 . Genetic analyses of consanguineous families have identified at least 18 MCPH genes that regulate RGC function and NPC expansion, and encode proteins essential for centrosome and cilium biogenesis and various functions in transcriptional regulation, DNA damage responses and mitosis 1 .
We ascertained a five-generation family in which ten individuals born to consanguineous couples presented with moderate to severe MCPH, varying degree of intellectual disabilities and impaired cognitive function; four affected individuals exhibited severe speech impairment, but none had seizures or epileptic symptoms ( Fig. 1a,b ; Supplementary Table 1 ).
Cerebral MRI scans of one patient (V-14) showed decreased craniofacial ratio, slanting forehead and normal dimensions of the ventricular system ( Fig. 1c) . Volume loss was observed in the corpus callosum, especially in the anterior half. Linkage analysis identified two possible loss of heterozygosity (LOH) regions at chromosome 2q21.3 and 22q13.1-13.2. Further analysis using short tandem repeat and nucleotide polymorphism markers excluded linkage to 2q21.3 and confirmed linkage with a maximum LOD score Z=8.61 to a 2.5 Mb homozygous region at 22q13.1-13.2 (40,436,371-43,001,960 bp, hg38) ( Fig. 1a, Supplementary Fig. 1a ). This region contains 49 protein coding genes. Whole Exome Sequencing (WES) identified a very rare homozygous c.465G>C (p.W155C) missense mutation in Ribosomal RNA Processing 7 Homolog A, RRP7A, which is located within the linkage region ( Fig. 1d, Supplementary Fig. 1b ). Sanger sequencing confirmed that all affected family members were homozygous for the mutation, while parents of affected children were heterozygous carriers (Fig. 1a ). The mutation was absent in 300 controls of Pakistani origin. The allele frequency of the mutation is 3.3E-05 in the South Asian population and the mutation is not present in 107,000 controls of other ethnicities (gnomad.broadinstitute.org). W155 in RRP7A is conserved from zebrafish to humans ( Supplementary Fig. 1c ), and in silico analysis of the effect of p.W155C mutation using the Combined Annotation Dependent Depletion (CADD) algorithm 7 resulted in a scaled CADD score of 27.1, supporting that the mutation is pathogenic.
To evaluate the spatial expression of RRP7A in the developing human brain, DAB staining (bright-field immunohistochemistry) and immunofluorescence microscopy (IFM) were performed on sections of midgestation human fetal brains, in which all proliferative zones of the developing cortex are represented 8 . Examination of the parietal cortex showed expression of RRP7A in RGCs at the VZ, ISVZ, OSVZ, intermediate zone/outer fibre layer, subplate and cortical plate as well as localization to ependymal cilia at the VZ (Fig. 1e-h) . See Supplementary Fig. 2a for indications of the individual zones stained for Vimentin that marks RGCs. Further, evaluation of the temporal cortex and hippocampal formation revealed RRP7A localization to RGC fibres in the cortical plate ( Fig. 1i-k) and at the outer surface along the fimbria (Fig. 1l,m) , which is devoid of neurons at this stage as confirmed by lack of βIII-tubulin staining ( Supplementary Fig. 2b ). RRP7A also localizes to other brain areas and cell types, including the meninges and endothelial cells lining the brain blood vessels ( Supplementary Fig. 2c ). The identification of OSVZ as the key germinal zone responsible for neocortical expansion 9 and the subsequent characterization of its population of Hopxpositive basal RGCs provided additional insight in cortical and evolutionary neocortical expansion 10 .
The prominent RRP7A immunoreactivity of apical truncated RG and in particular bRG following the discontinuity of the radial glia scaffold in human neocortex present at midgestation 2 indicates an important role in neural and neuronal development.
To assess the role of RRP7A in proliferation and neurogenesis, we used the CRISPR/Cas9 system to induce random deletions in exon 2 of the Rrp7a gene in P19CL6 cells, a mouse teratocarcinoma stem cell line that differentiates into neurons upon retinoic acid (RA) stimulation 11 ( Supplementary Fig. 3a,b ). Analysis of 94 clones revealed high genome editing efficiency, with an Rrp7a alteration in 53% of cell clones (data not shown). However, none of the observed mutations caused frameshift in both copies of Rrp7a. We therefore chose two clones (P19CL6 Rrp7a1/18 and P19CL6 Rrp7a8/33 ), both of which contain two mutant rrp7a alleles (an in-frame and a frameshift deletion, respectively, ( Supplementary Fig. 3c )), and analysed these in parallel with two wild-type (WT) clones (P19CL6 Rrp7aWT#1 and P19CL6 Rrp7aWT#2 ), which readily differentiate into neurons ( Supplementary Fig. 3d ). As expected, WB analysis showed that the mutant clones express reduced levels of lower molecular mass species of RRP7A compared to the WT clones ( Fig. 2a ) and IFM analysis showed that these clones proliferate slower than the WT clones ( Fig. 2b,c) . To investigate whether RRP7A is required for neuronal differentiation, WT and mutant clones were cultured to the same confluency of ca. 30% followed by RA stimulation (Fig. 2d ). In contrast to P19CL6 Rrp7a WT#1 , which formed neurons at linings of cell clusters at day 6 of stimulation and produced elaborate neuronal networks positive for Microtubule Associated Protein 2 (MAP2) and III-tubulin at day 9, differentiation was prominently reduced in the mutant clones ( Fig. 2d,e ). Impaired neurogenesis in the mutant clones was confirmed by SDS-PAGE and WB analyses, showing that P19CL6 Rrp7aWT#1 but not P19CL6 Rrp7a8/33 displayed significant upregulation of the neuroectodermal lineage marker Paired Box 6 (PAX6) as well as III-tubulin and MAP2 during RA stimulation ( Fig. 2f-h ). Taken together, our data suggest that RRP7A promotes cell proliferation and is required for timely onset of neurogenesis and formation of elaborate networks of post-mitotic neurons.
A comprehensive cell-based siRNA screen previously implicated RRP7A in ribosome assembly 12 and the W155 residue is involved in the interaction of RRP7A with NOL6 (UTP22) 13 .
Since defective ribosome biogenesis is associated with cell cycle defects as well as neurodevelopmental disorders in combination with additional abnormalities 14, 15 , we investigated if the p.W155C mutation in RRP7A affects rRNA processing using patient-derived (human) dermal fibroblasts (HDFs). Initially, we compared the expression of RRP7A in control and patient HDFs using WB and qRT-PCR analyses and observed reduced RRP7A protein levels, but normal mRNA levels, in the latter ( Supplementary Fig. 4a,b ). Addition of proteasome inhibitor MG-132 restored RRP7A levels in patient HDFs to normal ( Supplementary Fig. 4a ), suggesting that the p.W155C mutation leads to proteolytic degradation of RRP7A. IFM analysis of control HDFs, either cultured in the presence of serum or synchronized to growth arrest by serum depletion, showed that RRP7A is localized in the cytosol and predominantly to nucleoli, which is the principal site of ribosome biogenesis, as well as to the centrosome and primary cilium ( Fig. 3a-c) . Similar results were obtained for patient-derived HDFs except that the RRP7A signal in nucleoli was significantly reduced in these cells compared to controls ( Fig. 3d-f ). This phenotype was recapitulated in hTERT RPE-1 (RPE-1) cells expressing FLAG-RRP7A-GFP WT or FLAG-RRP7A-GFP W155C ( Supplementary Fig. 4c -e), indicating that the p.W155C mutation impairs recruitment to nucleoli.
To investigate rRNA processing, total RNA from control and patient HDFs was analysed by northern blotting using oligo nucleotide probes targeting internal transcribed spacers 1 (ITS1) and 2 (ITS2). Fibroblasts from an MCPH patient with a mutation in the WDR62 gene 16-18 , which is unrelated to ribosome biogenesis, was included as a control. In human pre-rRNA processing, the 47S precursor is first cleaved at sites 01 and 02 to form 45S, followed by processing according to one of two main pathways ( Fig. 3g) [19] [20] [21] . The processing pattern in the RRP7A mutant differs from WT and the WDR62 mutant in three ways ( Fig. 3h ). First, there is a depletion of 41S in pathway 1 (probes a and b). Second, there is an accumulation of 30S in pathway 2 (probe a). Third, there is a depletion of 21S in both pathways (probes a and b). These observations are consistent with a deficiency in cleavage at site A0 in formation of 18S rRNA. Accumulation of 45S or a shift towards increased use of pathway 2 could not be resolved due to co-migration of 47S and 45S. In contrast to the deficiencies in the pathway leading to 18S rRNA, the pathway leading to 28S appeared unaffected as evidenced by equal signals corresponding to 32S and 12S, respectively. In siRNA knockdowns of RRP7A in HeLa cells, primary lung fibroblasts, and HTC-116 colon carcinoma cells, the phenotype was characterized as "21S down, 18S-E down" 12 . Furthermore, re-inspection of the published northern blots 12 suggest depletion of 41S and accumulation of 30S in RPP7A depleted cells. Thus, we conclude that the RRP7A mutation results in defective rRNA processing due to a deficiency in cleavage at site A0.
Since Rrp7a mutant P19CL6 clones and RRP7A patient HDFs generally proliferated slower than controls (data not shown) we speculated whether the observed defect in ribosome biogenesis in RRP7A mutant cells is correlated with a delay in cell cycle progression. To test this we monitored the assembly and resorption of the primary cilium, which is formed during quiescence to coordinate developmental signaling 22 as well as to retain cells in G 0 /G 1 23, 24 . Aberrant regulation of cilium resorption is thus linked to defects in proliferation-differentiation decisions of RGCs in the developing mouse neocortex 24 , and MCPH patient fibroblasts carrying a mutation in CENPJ present excessively long cilia, resulting in delayed ciliary disassembly and S phase entry, which in NPCs leads to premature differentiation and reduced brain size 25 . In cultured fibroblasts, cilium formation and resorption can be induced by serum withdrawal and re-addition, respectively. Following initial serum-induced cilium disassembly at G 0 /G 1 , cells are transiently reciliated to be deciliated again during S/G 2 concomitant with DNA synthesis 26 . Interestingly, IFM analysis showed that RRP7A patient HDFs grown in serum enriched medium, which normally suppresses ciliogenesis and promotes cilium resorption, display significantly higher ciliation frequency than controls (time=0 h; Fig. 4a,b ). In contrast, serum-depleted cells showed similar frequency and length of primary cilia in control and patient HDFs (Fig. 4b,c ), suggesting that the RRP7A mutant HDFs fail to deciliate during conditions permissive for proliferation. To address ciliary resorption, cells were deprived of serum for 48 hours and then grown 24 hours in serum-enriched medium. In accordance with previous studies 26 , ciliary resorption in control HDFs proceeded in two waves, first ciliary length was reduced after 6 hours of serum stimulation, followed by transient elongation at 12 hours and complete ciliary resorption at 24 hours post serum re-introduction ( Fig. 4d-f ). Patient HDFs also displayed shortened cilia at 6 hours of serum stimulation, but cilia proceeded to elongate at 12-24 hours post serumintroduction, which was associated with a high frequency of ciliated cells even after 24 hours ( Fig.   4d -f). WB analysis revealed that patient cells during serum re-introduction display delayed phosphorylation of retinoblastoma protein (RB), which marks cell cycle progression ( Fig. 4g,h) .
These results support the conclusion that the p.W155C mutation in RRP7A compromises cell cycle progression, which is coupled to the second wave of ciliary resorption. Our combined results from patient HDFs and P19CL6 cells thus indicate that RRP7A invalidation leads to a reduction in both proliferation and neuronal differentiation.
Finally, to investigate the role of RRP7A in brain development in vivo, we used zebrafish as a model. Whole mount in situ hybridization analysis of 2 days post fertilization (dpf) zebrafish embryos showed rrp7a expressed in the head of the embryo, including the brain and the eyes ( Fig. 5a ). We proceeded to study developmental defects associated with rrp7a depletion using a zebrafish line carrying a frameshift mutation in rrp7a ( Supplementary Fig. 5a ,c). Homozygous mutant progeny presented with a phenotype resembling primary microcephaly, characterized by significantly reduced size of the brain, but otherwise no gross abnormalities ( Fig. 5b-f ). In line with the observed defects in neurogenesis and cell cycle control in mutant P19CL6 cells and HDFs, reduced brain size was accompanied by a reduction in the number of cells in the pallium of 3 dpf rrp7a -/mutants embryos ( Fig. 5g ) as well as a marked reduction in the expression of the neural progenitor marker neurod1 and proliferation marker pcna in the developing brains of rrp7a -/mutants ( Fig. 5h ).
Ultimately, to consolidate the observations from patient HDFs, we analysed rRNA processing in WT and rrp7a -/zebrafish. The embryos were sorted according to phenotype based on morphological criteria and RT-PCR confirmed aberrant splicing of rrp7a mRNA in embryos with mutant phenotype ( Supplementary Fig. 5b ). Northern blotting analysis showed an altered pattern of processing intermediates and a pronounced depletion of mature 18S rRNA in the knock-out compared to WT fish while mature 28S and 28S processing intermediates appeared unaffected ( Fig. 5i ).
In conclusion, we have identified RRP7A as a novel disease gene in MCPH. Analyses of human fetal brains, zebrafish, cell models, and primary cells from patients showed that RRP7A regulates brain development, neurogenesis, ciliary resorption and cell proliferation and provide evidence for defective ribosome biogenesis as pathophysiological mechanism. While RRP7A was observed to localize to cilia and centrosomes in addition to nucleoli, it is currently unclear if and how the pool of RRP7A at the cilium-centrosome axis impinges on the disease phenotype. It will be interesting to address this in future studies; in particular whether cilium-localized RRP7A might directly promote ciliary disassembly prior to mitosis and/or regulate developmental signalling associated with RGC/NPC function and neurogenesis.
Materials and Methods

Patient samples
The study followed the declaration of Helsinki and was approved by institutional ethical committees.
The five generation family originates from the rural area in the Rahim Yar Khan district, in Punjab province of Pakistan. Informed consent was obtained from all participating individuals or their parents for the collection of blood and/or skin biopsy samples, genetic analyses, and publication of photos and genetic information. Blood samples from all available family members were collected in separated appropriate tubes for genomic DNA/RNA isolation. Skin biopsies from affected individuals were collected in DMEM for cell cultures. Genomic DNA was isolated from peripheral blood cells using phenol-chloroform extraction.
Magnetic resonance imaging
A magnetic resonance imaging (MRI) scan was performed for one affected individual at the Sheikh Zayed Hospital, Rahim Yar Khan. Multiplanar, multisequential FLAIR and diffusion images of brain MRI were obtained in axial, coronal and sagittal views and Images were analysed using syngo fastView (version 1.0.0.3, Siemens AG).
Genome-wide SNP array mapping and linkage analysis
To identify regions of homozygosity, deletions, or duplications, samples were genotyped on Genome-Wide Human SNP array 6.0 (Affymetrix Inc., Santa Clara, CA, USA). The analysis was performed in four patients (one from each loop) according to the manufacturer's standard protocol (Affymetrix). 
Data analysis was performed using
Genetic analysis
Direct sequencing of ASPM and linkage analysis of WDR62 and CENPJ, using microsatellite markers flanking each gene, was used to exclude the most common MCPH genes in the Pakistani population.
Following exclusion of the most commonly involved genes, linkage analysis was performed using Genome-Wide Human SNP 6.0 arrays. This analysis excluded linkage of rare copy number variants (CNVs). were performed by restriction digestion on amplified PCR products, using the HpyCH4V restriction enzyme. HpyCH4V restriction enzyme digestion products were analysed on 1.5% agarose gels.
Multiple alignment and homology modelling of RRP7A
Multiple protein sequences alignments to determine the conservation of the mutated amino acid (p.W155C) was done using the online alignment tool (http://www.uniprot.org/). RRP7A (>NP_056518.2) has 23% sequence similarity with the Ribosomal RNA-processing protein 7 [(RRP7)
Total RNA isolation, RT-PCR and qRT-PCR
To check for RRP7A splicing errors, total RNA was isolated from whole blood obtained from a patient (V.14) and a healthy control individual. Blood for RNA was collected in PAXgene blood RNA tubes, and was isolated using a PAXgene ® Blood RNA Kit (PreAnalyticX). One µg of total RNA was reverse transcribed using SuperScript™ II (Invitrogen, Carlsbad, CA), and oligo-dT primers (Invitrogen). To detect aberrant splicing, full length RRP7A gene products were PCR-amplified from first strand cDNA with gene specific primers 5'-ATGGTGGCGCGCAGGAGGAA-3' (forward) and 5'-GTACGGTCGGAATTTGCG-3' (reverse). The PCR products were analysed on 1% agarose gels, and subsequently directly sequenced in both directions. To check for the analysis of ribosomal RNA processing defects, total RNA was extracted from fresh cultures of primary fibroblasts obtained from an affected individual (V.14), an MCPH patient homozygous for WDR62 mutation (loss of function mutation due to microduplication (unpublished data)) and a normal control using QIAzol ® lysis reagent (Qiagen Inc., Valencia, CA) in accordance with the manufacturer's guidelines. Quality of extracted RNAs were checked by running samples in 1% agarose gels and quantification was done using NanoDrop™ ND-1000 spectrophotometer (Thermo Fisher Scientific Inc., Wilmington, USA).
In order to assess expression of RRP7A mRNA in primary fibroblast cultures, qRT-PCR was performed using Brilliant III Ultra-Fast SYBR® Green QPCR master mix (Agilent Technologies).
The qRT-PCR reactions were performed in triplicate and were analysed on an ABI 7500 fast system.
The data was normalized against the average expression value of two housekeeping genes (GAPDH and B2M, primer sequences available upon request).
Human brain tissue samples and immunohistochemistry
Eight brains from 7 weeks post conception (wpc) to 21 wpc were analysed. A 19 wpc midgestation fetus was chosen for the entire immunohistochemical analysis as material from all brain regions was available and all cell types present at this stage. The material was obtained from legal abortions.
Written and oral informed consent was given according to the Helsinki declaration II, approved by the 
Generation of CRISPR clones of P19CL6 cells
CRISPR was performed as previously described 28 Fig. 3e ).
Constructs
Using first strand cDNA obtained from a healthy donor as templates, full length coding sequence of the RRP7A (GenBank accession number NM_015703.4) was PCR amplified and cloned into the mammalian expression vector pEGFP-n1 using EcoRI and BamHI restriction sites. Two full length wild type expression constructs for RRP7A were generated; one containing a Green Fluorescent Protein (GFP)-tag at the C-terminus and another containing a FLAG-tag at the N-terminus and a C- 
SDS-PAGE and western blotting analyses
After washing in 1X ice cold PBS, cells were lysed in 1X SDS lysis buffer with Complete, EDTA- 
Immunocytochemistry
IFM was performed as previously described 31 . In brief, cells were fixed in 4% PFA and permeabilized in 0.2% Triton X-100. Blocking was performed using 5% BSA, and cells were incubated in primary antibodies for 1.5 hours at RT or overnight at 4°C. Secondary antibodies were incubated for 45 min, and DAPI staining performed for 30 seconds prior to mounting in mounting media containing 2% Npropyl gallate and sealed with nail polish. Details on antibodies concentrations and manufacturers are listed in Supplementary Tables 2 and 3 
Zebrafish maintenance
Embryos were maintained and staged as previously described 32, 33 and all experiments were conducted according to the guidelines of the Danish Animal Experiments Inspectorate. The rrp7a
(ENSDARG00000098934) mutant line (sa11429) was acquired from Zebrafish International Resource Center (ZIRC) 34 F3 embryos were raised to adulthood and outcrossed to TL wild-type strain. All analyses were performed on F5 embryos, generated by crosses of heterozygous F4 adult fish.
Zebrafish measurements and sectioning of embryos
Lateral and dorsal images of 3 days post fertilization (dpf) zebrafish embryos were taken under Zeiss AxioZoom V16 (Carl Zeiss, Brock Michelsen A/S, Denmark) (n= 29, per group). Trunk length, eye diameter, forebrain and full brain areas were measured using ImageJ software 35 and data were presented as mean ± SD. The 3 dpf zebrafish embryos were collected and fixed in 4% paraformaldehyde overnight at 4°C. Embryos were washed in 1X PBS, oriented and embedded in 5% agarose. The agarose block was dehydrated in alcohol solutions: 70% EtOH, overnight; 96% EtOH, overnight; 99% EtOH 3X 1h. The block was transferred into Xylene, 2X 1h and into paraffin overnight at 60°C. The block was embedded into fresh paraffin and 2 μm transverse sections were collected. Slides with the sections were dried overnight at 37°C followed by standard HE staining.
In situ hybridization in zebrafish
The RT-PCR fragments of neurod1 and pcna were amplified using the primers 5'-TAACCAGAGCATCCCATCAGC-3'/5'-GCGGCTTGACGTGAAAGATG-3' and 5'-AGTGGACAGCACATCTGCAC-3'/5'-TGTGACCGTCTTGGACAGAG-3' respectively and were cloned into the pCRII-TOPO vector (Invitrogen) for riboprobe synthesis. The plasmids were linearized and transcribed with SP6 or T7 RNA polymerases (Roche). Digoxygenin-labelled probes were used for single ISH and detected with NBT/BCIP (Roche). In situ hybridization was performed as described 36 . Embryos were analysed on a Zeiss Axio Zoom V16 microscope. 
Statistical analysis
25.
Gabriel annotated processing sites and a simplified outline of the two main processing pathways with shortlived precursors in grey. In pathway 1, cleavage of 45S occurs at sites A0 and 1 to produce 41S that is subsequently split into two parts by cleavage at site 2 to yield the direct precursors for the small and large subunit rRNAs, respectively. In pathway 2, this order is reversed, such that 45S is first cleaved at site 2 yielding precursors for the small and large subunit rRNAs. The target sites of oligo nucleotide probes a and b are indicated on the map. h, Northern blots of parallel gel runs of total RNA samples from control and patient HDFs with mutations in RRP7A (patient) and WDR62 (MCPH2 pt.), respectively. Black arrows indicate processing intermediates inferred from the analyses and grey arrows mark the migration of mature rRNA species as inferred from re-probing of the filters with probes targeting these RNA species. Supplementary Table 1 
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